Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Julie A. Ressler"'
Autor:
Stephen J Forman, Massimo D’Apuzzo, Renate Starr, Christine E Brown, Brenda Aguilar, Michael E Barish, Behnam Badie, Maryam Aftabizadeh, Marie Suzette Blanchard, Heini M Natri, Jamie R Wagner, Jinny A Paul, Julie A Ressler, Julie Kilpatrick, Paige Myers-McNamara, Tracey Stiller, Nicholas Benovich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/0af0c26f64584a338832e24f8c129f2a
Autor:
Stephen J Forman, Massimo D’Apuzzo, Renate Starr, Christine E Brown, Brenda Aguilar, Michael E Barish, Behnam Badie, Leo D Wang, Darya Alizadeh, Jonathan C Hibbard, Marie Suzette Blanchard, Heini M Natri, Dongrui Wang, Julie R Ostberg, Jamie R Wagner, Jinny A Paul, Aleksandr Filippov, Ammar Chaudhry, Julie A Ressler, Julie Kilpatrick, Paige Myers-McNamara, Mike Chen, Russell C Rockne, Joseph Georges, Jana Portnow, Nicholas E Banovich
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/5d48eacb917c48b9aaf39b4f5f3d073d
Autor:
Jonathan R. Young, Julie A. Ressler, Joanne E. Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T. Chen
Publikováno v:
Magnetic Resonance Imaging. 96:60-66
With the development of HER2-directed therapies, identifying non-invasive imaging biomarkers of HER2 status in breast cancer brain metastases has become increasingly important, particularly given the risks of tissue sampling within the brain and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cec4ba1c290486eb98af4670a13baf
https://doi.org/10.1016/j.mri.2022.11.009
https://doi.org/10.1016/j.mri.2022.11.009
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Figure S4. 18F-Fluorodeoxyglucose ( F-FDG)-CT/PET of subjects UPN031 and UPN033
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d673474abb794b94ed15a125fb07cc
https://doi.org/10.1158/1078-0432.22457762.v1
https://doi.org/10.1158/1078-0432.22457762.v1
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary methods. These are more detailed methods than can be included in the body of the article.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a03b87bb9a78bfdfe3ee2823e26c6cd5
https://doi.org/10.1158/1078-0432.22457753
https://doi.org/10.1158/1078-0432.22457753
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Supplementary Tables S1-3. Table S1. T cell Product Release Criteria. Table S2. Manufacturing Feasibility. Table S3. Characteristics of Patients Who Received Study Treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c9facdbfd4046390adb39d3f97dbea8
https://doi.org/10.1158/1078-0432.22457756
https://doi.org/10.1158/1078-0432.22457756
Autor:
Michael C. Jensen, Stephen J. Forman, Massimo D'Apuzzo, Jana Portnow, Julie A. Ressler, James R. Bading, Yubo Zhai, Christine Wright, Jamie Wagner, Renate Starr, Araceli Naranjo, Wen-Chung Chang, Julie R. Ostberg, Lihong Weng, Michael E. Barish, Behnam Badie, Christine E. Brown
Purpose: A first-in-human pilot safety and feasibility trial evaluating chimeric antigen receptor (CAR)–engineered, autologous primary human CD8+ cytotoxic T lymphocytes (CTL) targeting IL13Rα2 for the treatment of recurrent glioblastoma (GBM).Exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25abbb9db60c246c8d4457830fb35f5d
https://doi.org/10.1158/1078-0432.c.6523685
https://doi.org/10.1158/1078-0432.c.6523685
Autor:
Jonathan R. Young, Julie A. Ressler, Mark S. Shiroishi, Joanne E. Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T. Chen
Publikováno v:
Academic radiology.
With the development of HER2-directed therapies, identifying non-invasive imaging biomarkers of HER2 expression in breast cancer brain metastases has become increasingly important. The purpose of this study was to investigate whether relative cerebra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ee040e6759169a4f673656e83017c0c
https://pubmed.ncbi.nlm.nih.gov/36549990
https://pubmed.ncbi.nlm.nih.gov/36549990
Autor:
Behnam Badie, Revathiswari Tirughana, Marianne Z. Metz, Karen S. Aboody, M. Suzette Blanchard, Julie A. Ressler, Massimo D'Apuzzo, Julie Kilpatrick, Shu Mi, Vivi Tran, Timothy W. Synold, Jana Portnow
Publikováno v:
Cancer Gene Therapy. 28:294-306
Neural stem cells (NSCs) are tumor tropic and can be genetically modified to produce anti-cancer therapies locally in the brain. In a prior first-in-human study we demonstrated that a single dose of intracerebrally administered allogeneic NSCs, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97e3cf0573d7d3cefebf0fad6d813fc0
https://doi.org/10.1038/s41417-020-00219-y
https://doi.org/10.1038/s41417-020-00219-y
Autor:
Jana Portnow, Chetan Raj Lingaraju, Massimo D'Apuzzo, Jonathan Hibbard, Maryam Aftabizadeh, M. Suzette Blanchard, Paige McNamara, Stephen J. Forman, Jamie Wagner, Christine E. Brown, Julie Kilpatrick, Dongrui Wang, Michael E. Barish, Julie A. Ressler, Tracey Stiller, Ramsinh Dodia, Renate Starr, Behnam Badie, Baishakhi Barva
Publikováno v:
Neuro Oncol
Chlorotoxin (CLTX), a peptide component of scorpion venom, exhibits selective and broad binding to glioblastoma (GBM) and other tumors with minimal activity against non-malignant cells. We have developed a novel CAR that utilizes CLTX as the tumor ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c230b4f44078daa3145e2f7deee60c8e
https://europepmc.org/articles/PMC8598614/
https://europepmc.org/articles/PMC8598614/